Stockreport

Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering

Bicara Therapeutics Inc.  (BCAX) 
PDF BOSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bif [Read more]